Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,123 | 1,150 | 98.1% |
| Education | $350.85 | 11 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,956 | 251 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,101 | 105 | $0 (2024) |
| Lilly USA, LLC | $1,390 | 105 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,329 | 83 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,243 | 74 | $0 (2024) |
| Amgen Inc. | $1,111 | 77 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $970.13 | 67 | $0 (2024) |
| PFIZER INC. | $909.20 | 69 | $0 (2024) |
| ABBVIE INC. | $702.09 | 51 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $633.88 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,944 | 108 | Novo Nordisk Inc ($411.54) |
| 2023 | $2,962 | 166 | Novo Nordisk Inc ($552.52) |
| 2022 | $2,638 | 159 | Novo Nordisk Inc ($544.72) |
| 2021 | $3,136 | 184 | Novo Nordisk Inc ($798.08) |
| 2020 | $2,002 | 138 | Novo Nordisk Inc ($537.77) |
| 2019 | $1,762 | 116 | AstraZeneca Pharmaceuticals LP ($381.71) |
| 2018 | $2,154 | 142 | Novo Nordisk Inc ($435.94) |
| 2017 | $1,876 | 148 | Novo Nordisk Inc ($315.86) |
All Payment Transactions
1,161 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: VACCINES | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: DIABETES | ||||||
| 10/18/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: VACCINES | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Diabetes Care | ||||||
| 09/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 4,306 | 5,400 | $691,061 | $207,533 |
| 2022 | 48 | 4,468 | 5,677 | $669,077 | $186,674 |
| 2021 | 47 | 5,236 | 6,550 | $746,933 | $200,701 |
| 2020 | 48 | 5,290 | 7,888 | $740,702 | $183,716 |
All Medicare Procedures & Services
186 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 349 | 643 | $118,955 | $49,001 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 295 | 295 | $66,375 | $35,539 | 53.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 296 | 424 | $65,720 | $24,684 | 37.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 194 | 196 | $28,365 | $13,927 | 49.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 42 | 42 | $17,850 | $10,706 | 60.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 128 | 240 | $23,760 | $10,292 | 43.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 202 | 204 | $13,260 | $5,803 | 43.8% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 42 | 42 | $8,820 | $5,396 | 61.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 286 | 302 | $43,790 | $4,971 | 11.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 332 | 538 | $29,590 | $4,469 | 15.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 288 | 305 | $41,175 | $3,975 | 9.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 24 | 26 | $7,670 | $3,899 | 50.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 25 | 25 | $6,875 | $3,721 | 54.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 287 | 313 | $35,995 | $3,240 | 9.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 98 | 102 | $9,690 | $2,935 | 30.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 19 | 19 | $4,750 | $2,785 | 58.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 84 | 84 | $29,400 | $2,773 | 9.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 292 | 343 | $29,155 | $2,580 | 8.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 162 | 263 | $19,725 | $2,483 | 12.6% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 42 | 42 | $1,680 | $1,617 | 96.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 34 | 47 | $9,306 | $1,567 | 16.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 15 | 27 | $7,965 | $1,188 | 14.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 40 | 40 | $2,200 | $1,097 | 49.9% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 61 | 65 | $9,750 | $1,079 | 11.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 45 | 55 | $6,325 | $734.80 | 11.6% |
About Dr. Denise Kennedy, MD
Dr. Denise Kennedy, MD is a Family Medicine healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104867191.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Denise Kennedy, MD has received a total of $18,474 in payments from pharmaceutical and medical device companies, with $1,944 received in 2024. These payments were reported across 1,161 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($18,123).
As a Medicare-enrolled provider, Kennedy has provided services to 19,300 Medicare beneficiaries, totaling 25,515 services with total Medicare billing of $778,624. Data is available for 4 years (2020–2023), covering 186 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Augusta, GA
- Active Since 06/09/2006
- Last Updated 05/23/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1104867191
Products in Payments
- Ozempic (Drug) $1,767
- FARXIGA (Drug) $1,696
- JARDIANCE (Drug) $1,085
- Kerendia (Drug) $633.88
- XARELTO (Drug) $614.23
- Rybelsus (Drug) $567.74
- TRELEGY ELLIPTA (Drug) $560.73
- TRULICITY (Drug) $544.25
- Aimovig (Biological) $515.34
- MOUNJARO (Drug) $496.29
- Saxenda (Drug) $423.92
- Victoza (Drug) $368.12
- UBRELVY (Drug) $335.54
- SPRAVATO (Drug) $279.89
- XIFAXAN (Drug) $278.69
- Wegovy (Drug) $240.59
- REXULTI (Drug) $232.29
- NURTEC ODT (Drug) $225.80
- RYBELSUS (Drug) $221.55
- VRAYLAR (Drug) $202.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Augusta
Daron Ferris, Md, MD
Family Medicine — Payments: $51,831
Dr. Charlton Pickett, M.d, M.D
Family Medicine — Payments: $18,984
Dr. Robert Franklin, Md, MD
Family Medicine — Payments: $18,295
Dr. Anthony Smith, M.d, M.D
Family Medicine — Payments: $17,943
Dr. Phillip Kennedy, Md, MD
Family Medicine — Payments: $17,521
Dr. Andrew Vanalstine, M.d, M.D
Family Medicine — Payments: $16,745